Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA

Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007–08)

(2012) Ian Morrissey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009

(2011) Sandra S. Richter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftaroline versus Ceftriaxone in a Highly Penicillin-Resistant Pneumococcal Pneumonia Rabbit Model Using Simulated Human Dosing

(2011) Delphine Croisier-Bertin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VivoEfficacy of a Human-Simulated Regimen of Ceftaroline Combined with NXL104 against Extended-Spectrum-β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Enterobacteriaceae

(2011) Dora E. Wiskirchen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009

(2011) James A. Karlowsky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

(2011) Donald E. Low et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

(2011) T. M. File et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus

(2011) C. Jacqueline et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study

(2011) R. N. Jones et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Affinity of Ceftaroline and Other  -Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae

(2010) K. Kosowska-Shick et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

(2010) David R. Snydman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria

(2010) D. M. Citron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Ceftaroline on Normal Human Intestinal Microflora

(2010) G. Panagiotidis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline against Community-Associated Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Daptomycin-Nonsusceptible Staphylococcus aureus Isolates

(2010) L. Saravolatz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States

(2010) M. R. Jacobs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia

(2010) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates

(2010) Céline Vidaillac et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model

(2010) C. Jacqueline et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) M. H. Wilcox et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis

(2010) C. Jacqueline et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) G. R. Corey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study

(2010) R. N. Jones et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity

(2010) D. Biek et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity

(2010) G. L. Drusano   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae

(2010) H. Moisan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including  -Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

(2009) C. Vidaillac et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vivo Activity of a Novel Anti-Methicillin-Resistant Staphylococcus aureus Cephalosporin, Ceftaroline, against Vancomycin-Susceptible and -Resistant Enterococcus faecalis Strains in a Rabbit Endocarditis Model: a Comparative Study with Linezolid and Vancomycin

(2009) C. Jacqueline et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia

(2009) Ian Morrissey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae

(2008) L. McGee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

(2008) Y. Ge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus

(2008) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006

(2008) D. M. Sievert et al.   CLINICAL INFECTIOUS DISEASES

Antibiotic options for treating community-acquired MRSA

(2008) J Patrick Powell et al.   Expert Review of Anti-Infective Therapy

Co-opting the Cell Wall in Fighting Methicillin-ResistantStaphylococcus aureus: Potent Inhibition of PBP 2a by Two Anti-MRSA β-Lactam Antibiotics

(2008) Adriel Villegas-Estrada et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY